Delivery Order SPE2DB25D3108-SPE2DB25FPDKA
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,792.82 firm fixed-price contract is for the supply of 4,568,120,296 units of the prescription medication Tafinlar 75 mg capsule. The contract has a period of performance through May 23, 2025. This award is not associated with a set-aside program and is part of a larger $999,999,999.00 Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $7,940.72 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 120 capsules of Tafinlar, a cancer treatment medication, to be delivered to a facility in Conshohocken, Pennsylvania by September 11, 2023. As a major supplier of pharmaceuticals and medical supplies to the Department of Defense, Amerisourcebergen will fulfill this order from its corporate headquarters using its extensive distribution network to rapidly deliver this critical...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the cancer medication Tafinlar (50 mg capsules). The contract has a firm fixed price of $30,424.90 and a performance period ending on May 22, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,792.82, is for the delivery of 4,568,201,792 units of the medication Tafinlar 75 mg capsules. The contract has an ultimate completion date of June 2, 2025 and was awarded on May 9, 2025. The contract is not set aside and is open to full and open competition....
- The Defense Logistics Agency awarded a $15,881 delivery order to Amerisourcebergen Drug Corporation for 120 capsules of Tafinlar, a cancer medication, under firm fixed price terms. Performance will take place in Conshohocken, Pennsylvania over a three week period concluding in late August. The prime contractor, Amerisourcebergen Drug Corporation, will fulfill the order from its corporate headquarters. No major subcontractors or set aside designations were indicated. This order provides needed...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $14,281.08 to Amerisourcebergen Drug Corporation. Under the contract, Amerisourcebergen will provide 120 capsules of Tafinlar, a prescription medication used to treat certain types of skin cancer and lung cancer, to locations within the Conshohocken, Pennsylvania area. The order is funded by the Defense Logistics Agency and supports the agency's medical supply needs. Amerisourcebergen, a subsidiary of...
- The U.S. Defense Logistics Agency (DLA) awarded a $8,139.33 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 120 count capsules of the oncology medication TAFINLAR 75 mg. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical to provide a comprehensive range of medical commodities to support military treatment...
- This federal contract award, valued at $17,792.82, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order (SPE2DB25FGR57) with a firm fixed-price, non-set-aside contract type. It covers the delivery of 4,567,996,469 units of the prescription medication Tafinlar 75 mg capsule, with a performance period extending through May 13, 2025. Amerisourcebergen Drug Corp, headquartered in Conshohocken, Pennsylvania,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $16,278.68, is for the supply of Tafinlar 75 mg capsules. It is a firm fixed-price delivery order contract with an ultimate completion date of August 28, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
- The Defense Logistics Agency awarded a $7,940.72 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 120 capsules of Tafinlar, a cancer treatment medication. As the prime contractor, Amerisourcebergen will fulfill the order from its facility in Conshohocken, Pennsylvania by October 13, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics operations and works to ensure medical supplies are available to support military readiness and...
- SPE2DB25D3108Indefinite Delivery Contract
- SPE2DB25D3108-SPE2DB25FPDKADelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 120 capsules of Tafinlar 75 mg, a chemotherapy medication used primarily for melanoma treatment. This firm fixed-price delivery order, valued at $8,896.41, was awarded on July 21, 2025, with an ultimate completion date of August 11, 2025. The contract was not set aside and represents a competitively awarded transaction under the company's existing contract vehicle. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.9 million and extending through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, serving customers including the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, leverages this platform to fulfill critical medical procurement needs across multiple therapeutic domains for defense and military medical applications.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.9k | 7/21/25 |